Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
120 readers recommended
96 readers recommended
PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.
41 readers recommended
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.
21 readers recommended
Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...
302 readers recommended
end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.
49 readers recommended
New drug treatments are now available for children with diabetes following the recent approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...
59 readers recommended
Join diaTribe at the American Diabetes Association's 83rd scientific conference for insights on future diabetes care, medication, and the latest tech. Plus, explore...
37 readers recommended
Understand the stigma linked to medication use for diabetes and obesity management. Let's change the perception and enhance our healthcare conversations.
34 readers recommended
SGLT-2 inhibitors can protect your heart! This type of medicine is recommended for people with type 2 diabetes who have heart disease or risk factors related to heart...
52 readers recommended
FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and...
46 readers recommended
Reduce heart failure risk with FDA-approved Inpefa (sotagliflozin). Inhibiting SGLT-2 and SGLT-1, it outshines other medications. Learn more about its effectiveness and...
13 readers recommended
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
40 readers recommended
Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.
49 readers recommended
Early findings from a phase 3 clinical trial demonstrated that participants treated with 50 mg oral semaglutide achieved a remarkable weight loss of 17.4%. This research...
44 readers recommended
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
32 readers recommended
The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.
54 readers recommended
The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically...
97 readers recommended
Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s...
73 readers recommended
Mark Cuban’s Cost Plus Drug Company recently added SGLT-2 inhibitor Invokana to its list of available medications. The company, which uses an innovative business model...
32 readers recommended
California Gov. Gavin Newsom announced a $50-million contract with Civica Rx to produce the state’s own insulin, adding to the recent new policies aiming to make this...